Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |